169 related articles for article (PubMed ID: 22099965)
1. Evaluation of morphological/immunohistochemical versus nuclear medicine imaging modalities in detecting metastatic bone and/or marrow deposits in neuroblastoma patients.
Zaher Ael-S; Zaher AM; Moneer MM; El Gamal BM
J Egypt Natl Canc Inst; 2011 Jun; 23(2):79-88. PubMed ID: 22099965
[TBL] [Abstract][Full Text] [Related]
2. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
[TBL] [Abstract][Full Text] [Related]
3. Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scans.
Gordon I; Peters AM; Gutman A; Morony S; Dicks-Mireaux C; Pritchard J
J Nucl Med; 1990 Feb; 31(2):129-34. PubMed ID: 2313350
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the utility of
Gauguet JM; Pace-Emerson T; Grant FD; Shusterman S; DuBois SG; Frazier AL; Voss SD
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28449267
[TBL] [Abstract][Full Text] [Related]
5. Does I-131-MIBG underestimate skeletal disease burden in neuroblastoma?
Barai S; Bandopadhayaya GP; Malhotra A; Agarwal S; Kumar R; Dhanapathi H
J Postgrad Med; 2004; 50(4):257-60; discussion 260-1. PubMed ID: 15623965
[TBL] [Abstract][Full Text] [Related]
6. Iodine-131-metaiodobenzylguanidine and bone scintigraphy for the detection of neuroblastoma.
Shulkin BL; Shapiro B; Hutchinson RJ
J Nucl Med; 1992 Oct; 33(10):1735-40. PubMed ID: 1403138
[TBL] [Abstract][Full Text] [Related]
7. Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients.
Kushner BH; Yeung HW; Larson SM; Kramer K; Cheung NK
J Clin Oncol; 2001 Jul; 19(14):3397-405. PubMed ID: 11454888
[TBL] [Abstract][Full Text] [Related]
8. Impact of metaiodobenzylguanidine scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemotherapy.
Kushner BH; Yeh SD; Kramer K; Larson SM; Cheung NK
J Clin Oncol; 2003 Mar; 21(6):1082-6. PubMed ID: 12637474
[TBL] [Abstract][Full Text] [Related]
9. 131I-MIBG in the diagnosis of primary and metastatic neuroblastoma.
El-Maghraby T
Gulf J Oncolog; 2007 Jul; (2):33-41. PubMed ID: 20084722
[TBL] [Abstract][Full Text] [Related]
10. [Sensitivity and specificity of meta-iodobenzylguanidine (mIBG) scintigraphy in the evaluation of neuroblastoma: analysis of 115 cases].
Lumbroso J; Guermazi F; Hartmann O; Coornaert S; Rabarison Y; Lemerle J; Parmentier C
Bull Cancer; 1988; 75(1):97-106. PubMed ID: 3359060
[TBL] [Abstract][Full Text] [Related]
11. [The place of 99mTc-MDP skeletal scintigraphy in neuroblastoma. Is a new assessment necessary?].
Sautter-Bihl ML; Bihl H; Heinze HG
Nuklearmedizin; 1991 Feb; 30(1):7-12. PubMed ID: 2062676
[TBL] [Abstract][Full Text] [Related]
12. [Utility of the scintigraphy with (123)I MIBG in the diagnosis of neuroblastoma bone metastasis].
Mena Bares LM; Benítez Velazco A; Pérez Cuenca E; Maza Muret FR; Hidalgo Ramos FJ; Pacheco Capote C; Contreras Puertas PI; Latre Romero JM
Rev Esp Med Nucl; 2009; 28(4):208-9. PubMed ID: 19922836
[No Abstract] [Full Text] [Related]
13. Neuroblastoma: imaging evaluation by sequential Tc-99m MDP, I-131 MIBG, and Ga-67 citrate studies.
Garty I; Friedman A; Sandler MP; Kedar A
Clin Nucl Med; 1989 Jul; 14(7):515-22. PubMed ID: 2766633
[TBL] [Abstract][Full Text] [Related]
14. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of metaiodobenzylguanidine as a scintigraphic agent for the detection of neuroblastoma.
Parisi MT; Greene MK; Dykes TM; Moraldo TV; Sandler ED; Hattner RS
Invest Radiol; 1992 Oct; 27(10):768-73. PubMed ID: 1399431
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of stage 4 neuroblastoma patients by means of MIBG and 99mTc-MDP scintigraphy.
Turba E; Fagioli G; Mancini AF; Rosito P; Galli A; Alvisi P
J Nucl Biol Med (1991); 1993 Sep; 37(3):107-14. PubMed ID: 8218456
[TBL] [Abstract][Full Text] [Related]
17. Improving Detection of Metastatic Neuroblastoma in Bone Marrow Core Biopsies: A Proposed Immunohistochemical Approach.
Parsons LN; Gheorghe G; Yan K; Simpson P; Jarzembowski JA
Pediatr Dev Pathol; 2016; 19(3):230-6. PubMed ID: 26491958
[TBL] [Abstract][Full Text] [Related]
18. Diffuse bone marrow uptake [123I]MIBG in neuroblastoma: an "MIBG super scan" case report.
Giammarile F; Olier AL; Lumbroso J
Q J Nucl Med; 1995 Jun; 39(2):119-21. PubMed ID: 8574805
[TBL] [Abstract][Full Text] [Related]
19. 111In-pentetreotide versus bone scintigraphy in the detection of bony metastases of neuroblastoma.
Juweid ME; Menda Y; O'Dorisio MS; Bushnell D; Blake M; Madsen M; Johnson J; Graham MM
Nucl Med Commun; 2002 Oct; 23(10):983-9. PubMed ID: 12352597
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact and prognostic value of metaiodobenzylguanidine imaging in children with metastatic neuroblastoma.
Perel Y; Conway J; Kletzel M; Goldman J; Weiss S; Feyler A; Cohn SL
J Pediatr Hematol Oncol; 1999; 21(1):13-8. PubMed ID: 10029806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
